On this Healthcare Unfiltered episode, I am joined by my special guest Dr. Pamela Kunz, MD, Editor in Chief of the groundbreaking new publication, JCO Oncology Advances.
Dr. Kunz, known for her expertise in gastrointestinal cancers, shares the story of how she landed the prestigious role, offering insights into the rigorous interview process. She discusses her innovative approach to generating interest in the peer-review process and outlines the journal’s ambitious goals to promote open-access publishing and collaborate closely with the esteemed Journal of Clinical Oncology. With a wealth of experience, Dr. Kunz reveals the type of individuals who will comprise the journal’s Editorial Advisory Board as well as the proposed new journal sections that are novel to medical publishing.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
